According to a new study, small changes in quality improvement procedures enabled clinicians to use magnetic resonance imaging (MRI) scans to diagnose stroke patients before giving acute treatment, within 60 minutes of arrival. MRI scans provide detailed images but take longer to complete than computed tomography (CT) scans, which are commonly used in most centers.

Holographic Optical Technologies has made its Voxgram hologram technology available to the consumer market through its just-launched Kickstarter campaign.

Fluke Biomedical launched Advantage Training, an online center aimed at providing accessible training to the biomedical engineering community.

Five new studies evaluating the use of imaging and urine-based biomarkers as ways to improve prostate cancer detection will be presented during the 110th annual scientific meeting of the American Urological Association (AUA). The research will be highlighted by study authors during a special press conference. Scott Eggener, M.D., AUA spokesperson and associate professor of surgery for urologic oncology at the University of Chicago Medicine, will moderate the session.

Behavioral health technology company Polaris Health Directions and MD Anderson Cancer Center at Cooper have signed a memorandum of understanding to partner on an integrated medical-behavioral health pilot project. The project will use the Apple Watch to capture behavioral data that could affect the courses and outcomes of treatment for breast cancer patients.

Kalorama Information expects the nearly 25 billion-dollar market for electronic medical records (EMR) to grow well past the period where there are incentives for U.S. healthcare providers, according to a recent report. The healthcare market research publisher said penalties, system upgrades, international sales and continued efficiency improvements will grow the market 7-8 percent each year for the next five years. The market for EMR systems continues to increase as more physicians and hospitals use EMR and acquire EMR systems, and as hospitals and physician groups upgrade existing systems.

Two studies from Johns Hopkins Kimmel Cancer Center add to preliminary evidence that stereotactic body radiotherapy (SBRT) appears as safe and effective as standard radiation treatment for certain patients with pancreatic cancer whose tumors are advanced but have not spread.